Gracell Biotechnologies rises 37% on management intention to purchase shares
- Gracell Biotechnologies (NASDAQ:GRCL) rises 37%
after members of its senior management team informs the Company of their intention to use their personal funds to purchase the Company’s American depositary shares on the open market for an aggregate amount…
